Predicted to enable zinc ion binding activity. Predicted to be involved in several processes, including embryonic brain development; maintenance of postsynaptic density structure; and regulation of postsynaptic density assembly. Predicted to act upstream of or within establishment or maintenance of epithelial cell apical/basal polarity and neuron projection development. Predicted to be located in apicolateral plasma membrane; cytoplasm; and lateral plasma membrane. Predicted to be active in glutamatergic synapse and postsynaptic density. Orthologous to human PRICKLE2 (prickle planar cell polarity protein 2); PARTICIPATES IN Wnt signaling, the planar cell polarity pathway; Wnt signaling pathway; INTERACTS WITH 3,4-methylenedioxymethamphetamine; 6-propyl-2-thiouracil; all-trans-retinoic acid.
[Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of PRICKLE2 gene and [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in increased methylation of PRICKLE2 gene
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PRICKLE2 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PRICKLE2 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PRICKLE2 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PRICKLE2 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PRICKLE2 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PRICKLE2 mRNA
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of PRICKLE2-AS1 mRNA] which results in increased expression of PRICKLE2 mRNA more ...
[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRICKLE2 mRNA
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of PRICKLE2-AS1 mRNA] which results in increased expression of PRICKLE2 mRNA and [[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of PRICKLE2-AS3 mRNA] which results in increased expression of PRICKLE2 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PRICKLE2 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PRICKLE2 mRNA
[Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of PRICKLE2 gene and [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in increased methylation of PRICKLE2 gene
[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of PRICKLE2-AS1 mRNA] which results in increased expression of PRICKLE2 mRNA and [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of PRICKLE2-AS3 mRNA] which results in increased expression of PRICKLE2 mRNA
[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRICKLE2 mRNA
[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRICKLE2 mRNA